Vaxcyte PCVX Institutional Ownership

Updated Oct 11, 2026

Vaxcyte, Inc. (NASDAQ:PCVX) was reported as a holding by 329 institutional investors in 13F filings for the quarter ended June 30, 2026.

• Total shares held in Vaxcyte rose 2.72% versus Q1 2026, while the number of holders rose 12.67% versus Q2 2025.
• Among the 329 holders of Vaxcyte, 181 added to their positions, 101 reduced their stakes and 47 left their positions unchanged.
• The aggregate institutional position in Vaxcyte was 166.86Mn shares at the end of Q2 2026, up 4.41Mn from the prior quarter and up 21.24Mn from a year earlier.
• FMR LLC held the largest position in PCVX at 20.85Mn shares as of June 30, 2026.
• Among holders that already owned Vaxcyte, the biggest buyers in Q2 2026 were FMR LLC (+4.36Mn shares), T. Rowe Price Associates Inc (+2.01Mn shares), Wellington Management Group LLP (+1.39Mn shares), BlackRock, Inc. (+1.1Mn shares) and State Street Corp (+911.18K shares).
• Among holders that kept a stake in Vaxcyte, the biggest sellers in Q2 2026 were Paradigm Biocapital Advisors LP (-2.67Mn shares), Jennison Associates LLC (-1.22Mn shares), Westfield Capital Management Co LP (-1.17Mn shares), Assenagon Asset Management S.A. (-1.06Mn shares) and D. E. Shaw & Co., Inc. (-963.45K shares).
• According to Business Quant data, the leading holders of PCVX for Q2 2026 were FMR LLC (20.85Mn shares), Jupiter Topco LLC (17.97Mn shares), T. Rowe Price Investment Management, Inc. (12.21Mn shares), BlackRock, Inc. (12.07Mn shares), Ra Capital Management, L.P. (11.47Mn shares), Wellington Management Group LLP (7Mn shares), Vanguard Portfolio Management LLC (6.59Mn shares), Vanguard Capital Management LLC (6.35Mn shares), State Street Corp (5.35Mn shares) and Deep Track Capital, LP (4.3Mn shares).